| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
| RE49222 | Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same | Oct 30, 19 | Sep 27, 22 | DAIKIN INDUSTRIES, LTD.; Osaka University; |
| RE47929 | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | Nov 27, 18 | Apr 07, 20 | Bristol-Myers Squibb Company |
| RE47396 | Compositions and methods for inhibition of the JAK pathway | Oct 20, 15 | May 21, 19 | Rigel Pharmaceuticals Inc. |
| 9999692 | Radiolabelling process | Mar 28, 14 | Jun 19, 18 | GE Healthcare Limited |
| 9994508 | Versatile and functionalised intermediates for the synthesis of vitamin D and novel vitamin D derivatives | Dec 09, 13 | Jun 12, 18 | Endotherm GmbH |
| 9993798 | Complex comprising oxidative dehydrogenation unit | Dec 01, 16 | Jun 12, 18 | NOVA CHEMICALS (INTERNATIONAL) SA |
| 9994504 | High temperature isomerization of (E)-1-chloro-3,3,3-trifluoropropene to (Z)-1-chloro-3,3,3-trifluoropropene | May 05, 17 | Jun 12, 18 | Honeywell International Inc. |
| 9987381 | Radioligands for imaging the LPA-1 receptor | Oct 31, 14 | Jun 05, 18 | Bristol Myers Squibb Company; The Trustees of Yale University; |
| 9988322 | Process for fluorinating compounds | Nov 12, 14 | Jun 05, 18 | Dow AgroSciences LLC; Regents of the University of Michigan; |
| 9987382 | Radiotracer compositions | Oct 07, 15 | Jun 05, 18 | GE Healthcare Limited |
| 9981961 | Deoxycytidine kinase inhibitors | Jan 31, 17 | May 29, 18 | The Regents of the University of California; The Board of Trustees of the University of Illinois; |
| 9981977 | Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst | Dec 26, 12 | May 29, 18 | The Regents of the University of California |
| 9982316 | Organo-catalytic biomass deconstruction | Aug 21, 17 | May 29, 18 | Virent, Inc. |
| 9981944 | GDF-8 inhibitors | Feb 15, 16 | May 29, 18 | RIGEL PHARMACEUTICALS, INC.; Bristol Myers Squibb Company; |
| 9981922 | KDM1A inhibitors for the treatment of disease | Feb 12, 16 | May 29, 18 | Imago Biosciences, Inc. |
| 9974869 | Chelated PSMA inhibitors | Aug 24, 16 | May 22, 18 | CANCER TARGETED TECHNOLOGY LLC |
| 9974790 | Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors | Nov 21, 16 | May 22, 18 | Incyte Corporation; Incyte Holdings Corporation; |
| 9968606 | Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof | May 18, 17 | May 15, 18 | NeuForm Pharmaceuticals, Inc. |
| 9969768 | Oleanolic acid methyl ester derivatives | Nov 16, 17 | May 15, 18 | King Saud University |